Mostrando 3 resultados de: 3
Filtros aplicados
Cuba's national clinical trials coordinating center: Emergence, evolution, and main results
OtherAbstract: The rapid development of Cuba's pharmaceutical industry in the 1990s created a need for structures tPalabras claves:Clinical evaluation, Clinical trial, Contract research organization, Cuba, Drug industryAutores:Jiménez G., López I., Martha M. Fors-López, Pascual M.A., Torres A.Fuentes:scopusDe Marco Formula effectiveness as an adjunctive therapy to prevent infected ischemic diabetic foot amputation and reduce plasma fibrinogen
ArticleAbstract: Background: De Marco Formula (DMF) is a new procaine chemical combination of Procaine HCl and polyviPalabras claves:amputation, De Marco formula, diabetic foot, Fibrinogen, polyvinylpyrrolidone, ProcaineAutores:Carretero J., Duarte H., MARTHA FORS, Martha M. Fors-López, Mesa M., Vilas M.Fuentes:googlescopusThe Cuban Public Registry of Clinical Trials: Primary registry of World Health Organization
ArticleAbstract: Despite the importance of randomized trials for well-informed decisions in health care, a large propPalabras claves:Clinical trial, Clinical trials registry, Cuba, Cuban Public Registry of Clinical Trials, Trial registrationAutores:Cachimaille Y., Cobas J., López I., López M.P., Martha M. Fors-López, Rivero G.J., Rodríguez J., Torres A.Fuentes:scopus